Advertisement

Topics

A good example of an option-to-buy deal that worked. Win-win. Astellas Acquires Collaboration Partner Potenza, Adding Cancer Immunotherapy Programs https://www.genengnews.com/news/astellas-acquires-collaboration-partner-potenza-therapeutics-adding-ca

20:09 EST 18 Dec 2018 | Genetic Engineering News

A good example of an option-to-buy deal that worked. Win-win. Astellas Acquires Collaboration Partner Potenza, Adding Cancer Immunotherapy Programs https://www.genengnews.com/news/astellas-acquires-collaboration-partner-potenza-therapeutics-adding-cancer-immunotherapy-programs/ … via

Original Article: A good example of an option-to-buy deal that worked. Win-win. Astellas Acquires Collaboration Partner Potenza, Adding Cancer Immunotherapy Programs https://www.genengnews.com/news/astellas-acquires-collaboration-partner-potenza-therapeutics-adding-ca

NEXT ARTICLE

More From BioPortfolio on "A good example of an option-to-buy deal that worked. Win-win. Astellas Acquires Collaboration Partner Potenza, Adding Cancer Immunotherapy Programs https://www.genengnews.com/news/astellas-acquires-collaboration-partner-potenza-therapeutics-adding-ca"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...